Advertisement
Research Article

GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma

  • Karin E. Smedby equal contributor,

    equal contributor Contributed equally to this work with: Karin E. Smedby, Jia Nee Foo

    Affiliation: Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden

    X
  • Jia Nee Foo equal contributor,

    equal contributor Contributed equally to this work with: Karin E. Smedby, Jia Nee Foo

    Affiliation: Human Genetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore

    X
  • Christine F. Skibola ,

    Affiliation: Division of Environmental Health Sciences, School of Public Health, University of California Berkeley, Berkeley, California, United States of America

    ‡ These authors also contributed equally to this work.

    X
  • Hatef Darabi ,

    Affiliation: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

    ‡ These authors also contributed equally to this work.

    X
  • Lucia Conde,

    Affiliation: Division of Environmental Health Sciences, School of Public Health, University of California Berkeley, Berkeley, California, United States of America

    X
  • Henrik Hjalgrim,

    Affiliation: Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark

    X
  • Vikrant Kumar,

    Affiliation: Human Genetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore

    X
  • Ellen T. Chang,

    Affiliations: Cancer Prevention Institute of California, Fremont, California, United States of America, Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, United States of America

    X
  • Nathaniel Rothman,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • James R. Cerhan,

    Affiliation: College of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Angela R. Brooks-Wilson,

    Affiliations: British Columbia Cancer Research Center, British Columbia Cancer Agency, Vancouver, Canada, Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, Canada

    X
  • Emil Rehnberg,

    Affiliation: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

    X
  • Ishak D. Irwan,

    Affiliation: Human Genetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore

    X
  • Lars P. Ryder,

    Affiliation: Department of Clinical Immunology, University Hospital of Copenhagen, Copenhagen, Denmark

    X
  • Peter N. Brown,

    Affiliation: Department of Haematology, Copenhagen University Hospital, Copenhagen, Denmark

    X
  • Paige M. Bracci,

    Affiliation: Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America

    X
  • Luz Agana,

    Affiliation: Division of Environmental Health Sciences, School of Public Health, University of California Berkeley, Berkeley, California, United States of America

    X
  • Jacques Riby,

    Affiliation: Division of Environmental Health Sciences, School of Public Health, University of California Berkeley, Berkeley, California, United States of America

    X
  • Wendy Cozen,

    Affiliation: Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America

    X
  • Scott Davis,

    Affiliations: Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, University of Washington, Seattle, Washington, United States of America

    X
  • Patricia Hartge,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Lindsay M. Morton,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Richard K. Severson,

    Affiliations: Department of Family Medicine and Public Health Sciences, Wayne State University, Detroit, Michigan, United States of America, Karmanos Cancer Institute, Detroit, Michigan, United States of America

    X
  • Sophia S. Wang,

    Affiliations: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America, Division of Etiology, Beckman Research Institute and the City of Hope, Duarte, California, United States of America

    X
  • Susan L. Slager,

    Affiliation: College of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Zachary S. Fredericksen,

    Affiliation: College of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Anne J. Novak,

    Affiliation: College of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Neil E. Kay,

    Affiliation: College of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Thomas M. Habermann,

    Affiliation: College of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Bruce Armstrong,

    Affiliation: Sydney School of Public Health, The University of Sydney, Sydney, Australia

    X
  • Anne Kricker,

    Affiliation: Sydney School of Public Health, The University of Sydney, Sydney, Australia

    X
  • Sam Milliken,

    Affiliation: Department of Haematology, St. Vincent's Hospital, Sydney, Australia

    X
  • Mark P. Purdue,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Claire M. Vajdic,

    Affiliation: University of New South Wales Cancer Research Center, Prince of Wales Clinical School, Sydney, Australia

    X
  • Peter Boyle,

    Affiliation: International Prevention Research Institute, Lyon, France

    X
  • Qing Lan,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Shelia H. Zahm,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Yawei Zhang,

    Affiliation: School of Public Health, Yale University, New Haven, Connecticut, United States of America

    X
  • Tongzhang Zheng,

    Affiliation: School of Public Health, Yale University, New Haven, Connecticut, United States of America

    X
  • Stephen Leach,

    Affiliation: Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada

    X
  • John J. Spinelli,

    Affiliations: British Columbia Cancer Research Center, British Columbia Cancer Agency, Vancouver, Canada, School of Population and Public Health, University of British Columbia, Vancouver, Canada

    X
  • Martyn T. Smith,

    Affiliation: Division of Environmental Health Sciences, School of Public Health, University of California Berkeley, Berkeley, California, United States of America

    X
  • Stephen J. Chanock,

    Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Leonid Padyukov,

    Affiliation: Rheumatology Unit, Department of Medicine, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden

    X
  • Lars Alfredsson,

    Affiliation: Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

    X
  • Lars Klareskog,

    Affiliation: Rheumatology Unit, Department of Medicine, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden

    X
  • Bengt Glimelius,

    Affiliations: Department of Pathology and Oncology, Karolinska Institutet, Stockholm, Sweden, Department of Radiology, Oncology, and Radiation Sciences, Uppsala University, Uppsala, Sweden

    X
  • Mads Melbye,

    Affiliation: Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark

    X
  • Edison T. Liu,

    Affiliation: Human Genetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore

    X
  • Hans-Olov Adami,

    Affiliations: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Keith Humphreys ,

    Affiliation: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

    These authors also contributed equally to this work.

    X
  • Jianjun Liu mail

    liuj3@gis.a-star.edu.sg

    Affiliation: Human Genetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore

    These authors also contributed equally to this work.

    X
  • Published: April 21, 2011
  • DOI: 10.1371/journal.pgen.1001378

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.